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Summary
Class lI genes of the human major histocompatibility complex (MHC) are highly polymorphic.
Allelic variation of structural genes provides diversity in immune cell interactions, contributing
to the formation of the T cell repertoire and to susceptibility to certain autoimmune diseases.
We now report that allelic polymorphism also exists in the promoter and upstream regulatory
regions (URR) ofhuman histocompatibility leukocyte antigen (HLA)class II genes. Nucleotide
sequencing of these regulatory regions of seven alleles of the DQB locus reveals a number of
allele-specific polymorphisms, some of which lie in functionally critical consensus regions thought
to be highly conserved in class II promoters. These sequence differences also correspondto allelic
differences in binding of nuclear proteins to the URR. Fragments of the URR of two DQB
alleles were analyzed for binding to nuclear proteins extracted from human B lymphoblastoid
cell lines (B-LCL). Gel retardation assays showed substantially different banding patterns to the
two promoters, including prominent variation in nuclear protein binding to the partially conserved
X box regions and a novel upstream polymorphic sequence element . Comparison of these two
polymorphic alleles in a transient expression system demonstrated a marked difference in their
promoter strengths determined by relative abilities to initiate transcription of the chloramphenicol
acetyltransferase reporter gene in human B-LCL. Shuttling of URR sequences between alleles
showed that functional variation corresponded to both the X box and upstream sequence
polymorphic sites. These findings identify an important source of MHC class II diversity, and
suggest the possibility that such regulatory region polymorphisms may confer allelic differences
in expression, inducibility, and/or tissue specificity of class II molecules.
C
lass II molecules of the MHC are cell surface heterodi-
mers composed ofcx and0 polypeptides. Structural vari-
ation among the MHC class II molecules is key to functional
differences where, as part of the trimolecular complex with
peptide and T cell receptor, the class II molecule participates
in immune activation events which lead to histoincompati-
bility, immune recognition, and disease susceptibility (1-3).
Variation among class II molecules is predominantly of two
types, one of which is germline genetic polymorphism, with
multiple alleles existing at various loci within the MHC gene
complex (4). This type ofpolymorphism leads to differential
peptide recognition and binding by the classII molecules en-
coded by individual alleles (5, 6) . Another source of varia-
tion arises from the differential ability of certain u chains
to pair with certain ,l3 chains to form combinatorial dimers
on the cell surface (7, 8). We have examined a possible third
type of polymorphism; namely, transcriptional variation be-
tween different class II alleles.
Regulated inducible and tissue-specific transcription of
MHC class II genes is a complex system involving cis-acting
sequence elements and trans-acting protein factors. Analysis
of transcriptional control elements involved in human class
II gene regulation have been reported for the nonpolymorphic
HLA-DRA1 gene (9, 10) and for the HLA-DQw2 DQB1
gene (11-14). These studies have identified a number of con-
sensus nucleotide sequences present in the proximal pro-
moter/enhancer region conserved not only amonghumanclass
II genes, but also across species barriers. Recent studies have
begun to identify potential candidates for nuclear regulatory
proteins which bind to these consensus nucleotide sequences
and therefore presumably mediate the observed transcriptional
effects (15-20). Current models for DNA-protein interac-
tions which contribute to the function of class II promoter
regions suggest that at least four or five important regula-
tory regions exist upstream of the class II coding sequences
within the first 180 nucleotides, with additional important
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further upstream (21, 22). Although class Il genes are often
coordinately expressed (23, 24), transcriptional regulatory
regionscritical for constitutive and inducible class 11 expres-
sion differ somewhat betweenHLADRA1 and HLA-DQB1
promoter elements (11, 25). An unknown number of func-
tionally important proteins bind theseregulatory regions, and
interactions between some of these proteins are essential for
normal regulated gene transcription (17, 26).
To investigate potential interallelic promoter region poly-
morphism, we determined the nucleotide sequences for up-
stream regulatory regions of each of theprevalentHLADQB
alleles. A number ofallele-specificpolymorphisms, even within
functionally critical consensus regions, were found. Com-
parisonof thesepromoter-associatedelements in gel retarda-
tion assays revealed corresponding allelic differences in binding
ofnuclearproteins. Analysis of the same polymorphicalleles
in atransient expression system demonstrated a marked differ-
ence in their promoter strengths, determined by relative abil-
ities to initiate transcription of the chloramphenicol acetyl
transferase (CAT)' reporter gene in human B lympho-
blastoid cell lines (B-LCL).
Materials and Methods
Nucleotide Sequencing andCell Lines Used.
￿
Nucleotide sequences
for promoter-associated regions of the DQB1 gene were derived
from the following cells: DQ3.1 (DQB1"0301), ER (DR4) and
SWEIG (DR5); DQ3.2 (DQBl'0302), BSM (DR4) and BrEh
(DR4); DQ3.3 (DQB1'0303), HIG(DR9) and008 (DR9); DQ4
(DQBI"0401), KT3 (DR4) andMAD(DR8); DQ2 (DQB1"0201),
VAVY and reference 27; DQ1.2 (DQB1"0602), AMAI (DR2); and
DQ1.1 (DQB1"0601), HOM2 (DRI). 1 gg of DNA from each
cell line was amplifiedby PCRas described(28), annealingat 39°C
for28 cycles. The 3' primer used foramplification of allalleles was
5'-GTCCTGCAGACATAATTGAGACGAAG-3, whichanneals to
the region starting at position -13, designating the A of ATG
as +1, andincludes an introduced Pstl site. The 5' primer wasone
of thefollowing: 5'-CAGGGATCCCTTAGGCAT`ICAATCTTC-3,
which includes an introduced BamHI site and anneals beginning
at position -314 in all alleles except DQ1.1 and DQ1.2; 5'-CTC-
GGATCCAATCAATATTACAAAGATGTTY, which anneals at po-
sition -374 in DQ1.1 and DQ1.2 alleles and contains a BamHI
site; or 5'-CACGGTACCTGAAACATGATCCACATT3; which
anneals at position -618 and contains an introduced KpnI site.
Afterdigestionwith appropriate restriction endonucleases, amplified
DNAwas ligatedinto M13mp18andM13mpl9vectors, transfected
into JM101, and sequenced using the dideoxy method of Sanger
and Coulson (29). Multiple clones were sequenced in everycase.
Nuclear Extracts.
￿
The human EBVtransformed B-LCL BSM
used forpreparation ofnuclear extracts wasgrownin RPMI-Hepes
containing 10% fetal bovine serum and harvested in logarithmic
growth phase. Nuclearextracts were prepared essentially as described
by Shapiro et al. (30). Briefly, cellswere swollenin hypotonicbuffer
(10 mM Hepes, pH 7.9, 0.75 mM spermidine, 0.15 mM spermine,
0.1 mM EDTA, 0.1 mM EGTA, 10 mM KCI, and 1 mM dithio-
threitol) and then lysed by 5-6 strokes of a pestle B in a Dounce
'Abbreviations used in this paper. B-LCL, Blymphoblastoid cell lines;CAT,
chloramphenicol acetyl transferase; URR, upstream regulatory region.
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homogenizer. The nuclei were isolated by centrifugation and ex-
tracted by an ammonium sulfate solution (ti4 Mat 4°C),and nu-
clearproteins were precipitated with solid ammonium sulfate. All
buffers contained the proteinase inhibitors phenylmethylsulfonyi
fluoride (0.5 mM) andleupeptin (5 kg/ml) (Calbiochem-Behring
Corp., San Diego, CA). Protein activity was measured (Bio-Rad
Laboratories, Richmond, CA) and the nuclear extracts were fur-
ther purified by heparin-agarose chromatography (H6508, Type
I; Sigma Chemical Co., St. Louis, MO). 1 ml ofheparin-agarose
was used per 30--40 mg of protein extract. The columns were
equilibrated with 5 column volumes of 0.1 M TM, where the
molarity refers to themolar fraction of KCIused in theTM buffer
(50 mM Tris-HCI, pH 7.9, 1 mM EDTA, 1 mM dithiothreitol,
12.5 MM M9CIZ, 20% glycerol). After applying the nuclear ex-
tracts, thecolumnswere eluted successively with 2column volumes
of0.1 M TM, 0.2 MTM,0.4 MTM, and 1 MTM. 1-ml fractions
were collected andassayed for protein activity. Protein-containing
fractions from each elution were pooled, and their final protein
concentrationwasdetermined; pooled fractions were then assayed
forDNA-binding activity in gelretardation assays (see below). The
majorDNAbinding activity (85-90%) eluted with the0.4 MTM
buffer.
Gel Retardation Assays.
￿
Oligonucleotides were synthesized on
aDNA synthesizer (model 391; Applied Biosystems, Foster City,
CA). Double-stranded oligonucleotides were end-labeled with ei-
ther Klenow DNA polymerase (Boehringer Mannheim Biochem-
icals, Indianapolis, IN)or Terminal Transferase (BethesdaResearch
Laboratories, Gaithersburg, MD) (31). Fragments DQ3.1(I) and
DQ3.2(I) (see Fig. 2) were end-labeled at the PpuMI restriction
site with Klenow DNA polymerase. Gel retardation assays were
performed as described previously (32, 33); briefly, the DNA-
protein-binding reactions were prepared in a total volume of 25
WI reaction buffer containing 12 mM Hepes, pH 7.9, 60 mM KCI,
12% glycerol, 0.12 mM EDTA, and 0.3 mM dithiothreitol. 1-1.5
,ugofnuclear protein extract was preincubated with 0.2,ug(unless
otherwise indicated in figure legends) of nonspecific competitor
DNA poly(dI-dC) .poly(dI-dC) (Pharmacia Fine Chemicals, Pis-
cataway, NJ)for 20 minat room temperature. Afteradding 10,000
cpm of end-labeled double-stranded DNA fragment or oligonu-
cleotide (N0.2 ng of DNA), the samples were further incubated
for 10 min at room temperature (RT). For competition assays,
poly(dl-dC) and specific competitor DNA were preincubated for
20 minat room temperature followed by an incubation for 10 min
at room temperature afteradding thelabeled probe. DNA-protein
complexeswere separated from free probe on 4% polyacrylamide
gels in 0.25 x TBE (1 x TBE is 89 mM Tris, 89 mM boric Acid,
and 2 mM EDTA).
Transcription Assays.
￿
HincII-digested 549-bp fragments from
amplifiedpromoter elements oftheDQ3.1 andDQ3.2 alleles were
inserted into the polylinker of thepTCAT vector at the Smal site,
47 nucleotides upstream of the CAT gene, to form the pQ3.10
PlCATandpQ3.20P2CAT plasmids, respectively (see Fig.6). The
pTCAT vector (kindly provided by Richard Harland, University
of California at Berkeley) is a promoter test plasmid that lacks an
endogenous promoter for theCAT gene. A 62-bp fragment from
position -223 (AatII) to -158 (PpuMI) was removed from the
DQ3.1 clone, and the corresponding DQ3.2 62-bp fragment was
inserted in its place, to form thehybrid pQ3.1OP3CAT construct.
pQ3.1OP2CAT represents theDQ3.1 promoter fragment inserted
in the I5PCAT plasmid in reverse orientation. pQ3.113P4CAT and
pQ3.20P3CAT were subcloned from the pQ3.1S1P1CAT and
pQ3.20P2CAT, respectively, by removing promoter sequences 5'
of the AatII site at position -223.The nonchromatographic CAT assay used was modified from
that of Sleigh (34). Briefly, 10 Ag of each pTCATderived plasmid
was used to transfect 2 x 10' BSM cells, for 30 min in 200 Ag
DEAE-Dextran/ml, along with 1 Wg of a plasmid encoding the
S-galactosidasegene driven by the CMV immediate earlypromoter
(pEQ176, kindly provided by Adam Geballe, Fred Hutchinson
Cancer Research Center, Seattle, WA) as a control for transfection
efficiency. After incubation in 5% COZ at 37°C for 48 h, samples
were harvested and cells lysed by three cycles of freeze-thawing.
Supernatants were divided into two samples. One was used for the
13-galactosidase assay, modified from Miller (35), where the chlo-
rophenol red galactopyranoside color change was measured at
OD574. The other sample was heated at 60°C for 10 min, cen-
trifuged to remove subsequent precipitate, and assayed for CAT
activity. 70 p,l ofthis sample was mixedwith 20 jA18 mM chloram-
phenicol and 10 Al 14C-acetyl CoA (0.1 uCi), incubated for 4 h
at 37°C, extracted with 1 ml ethyl acetate, vortexed, and mi-
crofuged. 800 pl of the ethyl acetate phase was counted in a liquid
scintillation counter. CAT and (3-galactosidase values were well
within the linear range of the assays.
Results
Nucleotide Polymorphisms among HLA-DQB1 Alleles.
￿
To
investigate nucleotide polymorphism in class II upstream
regulatory regions (URR), we designed oligonucleotide
primers homologous to DQB consensus sequences encom-
passing both proximal promoter and upstream regulatory ele-
ments (27, 36) for amplification and nucleotide sequencing
of a series of DQB alleles. PCR was used to amplify and
clone gene segments from genomic DNA; seven different al-
leles were sequenced, with up to five representative cell lines
sequenced for each allele. The first 285 nucleotides 5' of the
ATG initiation codon for the class II polypeptide were se-
quenced for all alleles, with longer stretches up to 580 nucleo-
tides sequenced for the DQ3.1 and DQ3.2 alleles; sequences
are shown in Fig. 1.
In these URR, most of the polymorphisms appear to be
conserved within a haplotype. This is true regardless of the
origin of the cell lines; for example, cell line MAD was de-
rived from a DR8, DQ4 Caucasian, while KT3 was derived
from a DR4, DQ4 Japanese, and their DQ URR fragments
are identical. While it is perhaps not surprising that promoter
sequences are maintained within clusters sharing identical
DQB structural genes, a more unexpected relationship ap-
pears to exist between the different allelic groups as com-
pared to their structural gene counterparts. The hierarchy
of degree of homology which exists among the DQB struc-
tural genes is not paralleledamong their promoter sequences.
Within the regulatory sequences outlined in Fig. 1, the highest
degree of homology (>99%) exists in a cluster including
DQ3.2, DQ3.3, and DQ4, which vary by only a single nucleo-
tide, whereas DQ3.1 and DQ3.2 have 12 differences (95.6%
homology). In contrast, the structural genes of DQ3.1,
DQ3.2, and DQ3.3 are the most closely related among DQB
alleles, while DQ4 is much less homologous. URR from
the other DQ genes, DQ1, DQ2, and DQ3.1, each vary from
the "DQ3.2 cluster" and from each other by 3-7%, suggesting
that the DQ URR and structural genes may have evolved
independently.
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DQ3 .1
￿
GACTCTCCTAAAGCACATTA
DQ3 .2
DQ3 .1 GTGGTGGAACTGCAACTCACCATTATTTCCTTCTAAGAACCTTGCTTTTTTCACCAAAACTTAAGGCTCCTCAAAGTGTG
DQ3 .2 ___ .- .______ . . .______ . .__-___ . . . ._____ . .T.____C_ .C ._____ .- . .______- . .-___GG. .___
D03 .1 TCTAAGACAACAGCAGTAAAAATGTCTATGACAGCAATTTTCTCTCCCCTGAAATATGATCCCCACTTAATTTGCCCTAT
DQ3 .2 ------------____________ . .______ . .__-____ . . ._______ . . .___ .__ . . .______ . ._____ . . .C
DQ3 .1 TGAAAGAATCCCAAGTATGAAAACAACTGGTTTTTAATCAATATTACAAAGATGTTTACTGTTGAATCGCATTTTT/TTT
DQ3 .2 -------____ . . .-___A_ . . .__-_CA . ._______ . .___ .___ . ._______ . . .______- . .______ . .C_-_
DQ3 .1 GGCTTCTTAAAATCCCTTAGGCATTCAGTCTTCAGCTCTTCCATAATTGAGAGGAAATTTTCACCTCAAATGTTCATCCA
DQ3 .2
￿
--------------- .-----------A------------- T__ ._-______-________ . ._______ ._
DQ3 .3
￿
--------- T___
￿
-_________G_____
￿
___.____.______._
DQ4
￿
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￿
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DQ3 .1 GTGCAATTGGAAGACGTCACAGTGCCAGGCACTGGATTGAGAACCTTCACAAAAAAAAA///TCTGCCCAGAGACAGATG
DQ3 .2 ._______T.____ ._ . . ._______ .__G_____- .______- ._ .____ . .______ .TG_____-T . ._______-T
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￿
--------T----------
￿
--------- G
￿
______
￿
__ . ._ .____ . ._-______ATG ------ T---------- T
DQ4
￿
--------
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G ---- A------------------------- TG_
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_____T
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￿
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￿
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￿
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￿
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￿
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￿
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￿
Y BOX
￿
CCAAT
￿
-90
DQ3 .1 AGGTCCTTCAGCTCCAGTGCTGATTGGTTCCTTTCCAAGGGACCATCCAATCCTACCACGCATGGAAACATCCACAGGTT
D03 .2
￿
----------------------- ._______
￿
__________________G__ .-___G____- ._________
￿
.
DQ3 .3
￿
__ .-----------
￿
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￿
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￿
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￿
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￿
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￿
_
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￿
--- .------------------------------------------- _-
￿
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DQ1 .2
￿
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DQ1 .1
￿
-------- .---------- .---------- T-------- C-------------- G------- C-------
￿
____
DQ3 .1 TTTATTCTTTCTGCCAGGTACATCAGATCCATCAGGTCCGAGCTGTGTTGACTACCACTACTTTTCCCTTCGTCTCAATT
DQ3 .2 __ . . .-____ . . . . . . . . ._______-______A__ .___ . . . .__-_ ._____ . ._______
DQ3 .3 -----_____ . . .______ . . .__-______ ._______A_- ._______ ._____-___ .____
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DQ1 .2 ___-------- __--------- _ .--------------------- ---------- G_____
DQ1 .1 _____- . . .______ . ._______ . . .___ ._ .__-__T________ .____ .__--
Figure 1.
￿
Nucleotide sequences ofURR ofseven HLADQ alleles, desig-
nating the A of ATG as +1. See Materials and Methods for cells used.
The dashes represent nucleotideidentity to the DQ3.1 sequence, and slashes
represent the absence of a nucleotide at that position. Solid lines above
the sequences indicate the position of the consensus sequence elements,
W, X, and Y box, and the dyad symmetry element. These sequence data
are available from EMBL/GenBank/DDBJ under accession numbers
X55421-X55427.
While all URR sequences are >90% homologous, sig-
nificant polymorphism was found, including within the MHC
class II consensus sequence elements, the X and W boxes.
These two sequence elements, along with the consensus Y
box, are found in all murine and human class II genes so
far studied, and deletion of any of the three is sufficient to
drastically reduce or eliminate transcription (12, 25, 37).
Among the DQB alleles, the X box consensus element is
polymorphic at positions -161 and -172 (see Fig. 1) . Dif-
ferent alleles carry either a G or T at position -161, and
a C or a T at position -172. Some alleles also lack two nearby
nucleotides (a TG at positions -179 and -180), while the
DQ2 and DQ3.3 alleles have an A at -181. 5' of the X box,
a stretch of A's varies in length from 8 to 10, depending on
the allele. For the W box among the DQB URR, a single
nucleotide substitution is noted, a C for a G at position -202
in the DQ2 allele only. The transcriptional control sequence
known as the CCAAT box, and the Y box, which contains
an inverted CCAAT sequence (13, 25), are conserved among
DQ URR. However, scattered additional polymorphisms do
occur in the region between these elements.
DNA-Protein Interactions in the DQB1 URR.
￿
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Figure 2 .
￿
DQ URR fragments and double-stranded oligonucleotides used in gel retardation assays. The DNA sequences from -288 to -159 of
theDQ3 .1 andDQ3.2URR are shown as in Fig. 1 and are termedDQ3 .1(I) orDQ3.2(1), respectively . Fragment II encompasses polymorphic sequences
from -223 to -288, termed DQ3 .1(1I) or DQ3 .2(II) ; fragment III encompasses sequences from -223 to -159, termed DQ3 .1(III) orDQ3 .2(III) .
Oligonucleotides used in these studies span polymorphic sites which differ betweenURR oftheDQ3.1B andDQ3.2B genes . Boundaries ofthe double-
stranded oligonucleotides are shown.
allelic URR were evaluated for possible differential interac-
tions withDNA binding proteins. Fragments of the DQ3.1
and DQ3.2URR were used, encompassing sequences from
-159 to -288, which contain the consensusW and X box
sequence motifs, in addition to other polymorphic and non-
polymorphic sequences of potential interest. These fragments
are illustrated in Fig . 2. DQ3.1(I) and DQ3.2(I) fragments
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encompass this entire region; DQ3.1(II) andDQ3.2(II) up-
stream fragments andDQ3.1(III) andDQ3.2(III) downstream
fragments divide the longer fragments adjacent to theW box
element, and correspond to the DQ3.1 and DQ3.2 alleles,
respectively .
Nuclear proteins were extracted from the human B-LCL .
BSM and theURR fragments DQ3.1(I) andDQ3.2(I) were
Figure 3 .
￿
(A) Competition analyses for protein binding to theDQ3 .1(I) andDQ3 .2(I) fragment . LabeledDQ3 .2(I) (lanes 1-7) andDQ3 .1(I) (lanes
8-14) fragments were incubated with BSM nuclear extract. (Lanes 1 and 8) Reactions with no competitor DNA. Complex formation was tested in
the presence of unlabeled competitorDNA (in -200-fold excess) : (lanes 2 and 9) DQ3 .1(1) ; (lanes 3 and 10) DQ3.2(I) ; (lanes 4 and 11) DQ3 .1(II) ;
(lanes 5 and 12) DQ3.2(II) ; (lanes 6 and 13) DQ3.1(III); and (lanes 7 and 14) DQ3.2(III) . (B) Competition analyses for protein binding to the DQ3.2(I)
fragment . Labeled DQ3 .2(I) fragment was incubated with BSM nuclear extract (lane 1), and complex formation was inhibited with the following
nonlabeled competitorDNA (in -300-fold molar excess) : (lane 2)DQ3 .1(I); (lane3) DQ3 .2(I) ; (lane 4)DQ3 .1(II) ; (lane 5)DQ3 .2(II) ; (lane 6)DQ3.1(III) ;
and (lane 7) DQ3.2(III) .end-labeled and used as probes in gel retardation assays . Pro-
tein-DNA complexes seen after gel electrophoresis showed
several bands of different intensities and mobilities (Fig . 3) .
Comparison of lane 1 [DQ3.2(I)] and lane 8 [DQ3.1(I)] in
Fig. 3A highlights two particular complexes ofinterest . Bands
denoted A1 and A2, for theDQ3.1 andDQ3.2 alleles, respec-
tively, had similar mobility patterns but markedly varied in
intensity ; the intensity of complexA2 was consistentlymuch
higher than that ofA1 using identical nuclear extracts and
probes of similar specific activity. Another complex with fast
mobility was consistently observed as a unique band (B) for
the DQ3.2(I) probe.
Competition experiments were performed using unlabeled
DQ3 .2 andDQ3.1 fragments to inhibit formation of theA1
and A2 complexes . Comparisons between the smaller com-
petitiveURR fragments revealed major differences : the down-
stream DQ3.2 promoter fragment DQ3.2(III) competed both
complex A1 and A2 at a 200-fold molar excess (Fig . 3 A,
lanes 7 and 14) ; however, neither of the complexes were com-
peted away by the downstream DQ3 .1 promoter fragment
DQ3.1(III) (Fig . 3A, lanes 6 and 13) . The converse was seen
when using the upstream DQ3.1(II) andDQ3.2(II) fragments
as competitors : while the DQ3.2(II) fragment had no ac-
tivity as a competitor (Fig. 3 A, lanes 5 and 12), the DQ3.1(II)
fragment was an effective competitor for both complexes Al
andA2 (Fig . 3 A, lanes 4 and 11) . Even with high concentra-
tions of competitiveDNA, formation of complex A2 could
not be inhibited by either the upstream DQ3.2(II) fragment
or the downstream DQ3.1(III) fragment (Fig . 3 B, lanes 5
and 6, respectively), but was efficiently inhibited by the up-
stream DQ3.1 fragment and the downstream DQ3.2 frag-
ment (Fig. 3 B, lanes 4 and 7, respectively) .
To pinpoint the basis for these DNA-protein interactions,
synthetic double-stranded oligonucleotides were used as un-
labeled competitorDNA in similar gel retardation assays . A
set of cognate oligonucleotides containing the consensus X
box sequence motif and flanking sequences (see Fig. 2) was
constructed. TheX(DQ3.2) andX(DQ3.1) oligonucleotides
correspond to the DQ3.2 and DQ3 .1 allelic nucleotide se-
quence in this region, respectively. The X(DQ3.2/3.1) oli-
gonucleotide is a hybrid of theDQ3.1 andDQ3.2 sequences
in this region with DQ3.2-specific nucleotides TG at posi-
tion -179, -180 and the DQ3.1-specificC andG nucleotides
at positions -172 and -161 . Gel retardation assays showed
that both X(DQ3.2) and X(DQ3.2/3.1) competitorDNA
efficiently inhibited formation ofthe mobility complexes Al
and A2 while X(DQ3.1) did not (Fig . 4 A) .
Since formation of complex A2 is inhibited not only by
the DQ3.2(III) but also the X(DQ3 .2) DNA, we infer that
proteins interacting with theX box consensus element and/or
flanking sequences participate in the formation of theA2 com-
plex . Since formation of complex A2 was not inhibited by
either DQ3.1(III) or X(DQ3 .1), it appears that the affinity
of these proteins is less forX box-related sequences in the
DQ3.1 URR compared with the DQ3.2 URR. Since
X(DQ3.2/3.1) acts equally well as an inhibitor of complex
formation as X(DQ3.2), nucleotides at positions -179 and/or
-180 are likely important for this high affinity protein binding
site present in the DQ3.2 URR.
Gel retardation analysis ofnuclear proteins directlybound
Figure 4 .
￿
(A) Competition analyses with X box oligonucleotides . Binding reactions were carried out with BSM nuclear extract and the DQ3 .1(I)
(lane 1-7) and DQ3.2(I) (lane 8-14) labeled fragments. (Lanes 1 and 8) No competitor DNA ; (lanes 2, 3, 9, and 10) competition with X(3.1); (lanes
4, 5, 11, and 12) competition with X(DQ3.1/3.2) ; and (lanes 6, 7, 13, and 14) competition with X(DQ3.2) . Binding reactions contained 1,000-fold
molar excess competitor DNA to probe (lanes 2, 4, 6, 9, 11, and 13) or 2,500-fold molar excess to probe (lanes 3, 5, 7, 10, 12, and 14) . (B) Direct
binding analyses to X box oligonucleotides . Binding reactions were carried out with BSM nuclear extract and (lanes 1-4) labeled X(3 .1), (lanes 5-8)
labeled X(DQ3.1/3.2), or (lanes 9-12) labeled X(DQ3.2) . Each X box oligonucleotide was incubated with increasing amounts of poly(dl-dC):
(lanes 1, 5, and 9, 0.01 Ag ; (lanes 2, 6, and 10) 0.05 hg, (lanes 3, 7, and 11) 0.1 p,g, and (lanes 4, 8, and 12) 0.5 Ftg .
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nucleotides showed one major complex with the same mo-
bility for all probes (Fig. 4 B) . However, the intensity of the
complex bound to X(DQ3.1) was very low compared with
the X(DQ3.2) and X(DQ3.2/3.1) probes, consistent with
the existence ofa high affinity X box binding site in theDQ3.2
URR compared with the DQ3 .1 URR.
These gel retardation studies also identify another poly-
morphic site in theURR with consequences for DNA-pro-
tein interactions . Formation of both Al and A2 was com-
peted byDQ3.1(II) but not DQ3.2(II), indicating the likelihood
that proteins participating in the Al and A2 complexes also
bind to polymorphic sequences in the upstream region of the
DQ3 .1URR . There are only three polymorphic sites in the
region encompassed by theDQ3.1(II) fragment which differ
fromDQ3.2(II) . Oligonucleotides spanning each of these sites
(Fig . 2) were used as inhibitors of DNA-protein complexes.
Only the oligonucleotide corresponding to the URR site at
position -279 competed with the formation of complexes
Al and A2, completely inhibiting the Al complex, and par-
tially competing the A2 complex (Fig. 5) .
Several sites ofDNA-protein interaction in the upstream
URR did not vary between the alleles studied: Fig . 5 B shows
that theDQ3 .1(-264) competitorDNA specifically inhibits
one of the slower mobility complexes, termed C. Included
within the sequence of the DQ3.1(-264) oligonucleotide is
a potential regulatory site at -265 to -270 which has exact
sequence homology to the PU box, a purine-rich sequence
recognized by a macrophage andB cell-specific transcription
factor PU.1 (38) . Another slow mobility complex observed
in the gel retardation studies (data not shown) corresponds
to proteins interacting with a region of "dyad symmetry"
upstream of the W box (Fig . 1) . The symmetry, which in
DQ3.1 extends seven nucleotides in each direction from the
central nucleotide at position -214, is disrupted in DQ3.2 .
Two oligonucleotides were constructed : DQ3.1(-214) and
DQ3.2 (-214), havingDQ3.1 and DQ3.2 allele-specific se-
quences, respectively, in this area of dyad symmetry (Fig. 2) .
Gel retardation assays using these double-stranded oligonu-
cleotides as labeled probes showed one major complex with
the same mobility binding to both (data not shown) .
Allelic Variation in PromoterStrength.
￿
To compare transcrip-
tional activity of the DQ3.1 and DQ3.2 URR, a transient
expression system was used, where the ability of portions
of these URR to drive transcription of the CAT reporter
gene was assayed . URR fragments inserted into the pTCAT
vector were used to co-transient the humanB-LCL BSM to-
gether with a plasmid (pEQ176) encoding (3-galactosidase,
serving as an internal standard control for transfection effi-
ciency. ThepTCAT vector contains no intrinsic promoter or
enhancer elements adjacent to the CAT gene; transfection
with the vector alone gave no detectable CAT activity above
background levels in the BSM cell extracts. As a result, the
CAT activity observed when transfecting the URR-pTCAT
constructs into BSM cells is due to the activity of the min-
imalDQ promoter elements through position -210 of the
Figure 5 .
￿
(A) Competition analyses with DQ3.1(-279), DQ3.1(-264), and DQ3.1(-232) competitorDNA . Binding reactions were carried out
with BSM nuclear extract and the DQ3 .2(I) (lanes 1-7) and DQ3 .1(I) (lane 8-14) probes. (Lane 1 and 8) No competitor DNA; (lanes 2, 3, 9, and
10) competition withDQ3.1(-279) ; (lanes 4, 5, 11, and 12) competition withDQ3.1(-264) ; (lanes 6, 7, 13, and 14) competition withDQ3.1(-232) .
Binding reactions contained 1,000 molar excess competitor DNA to probe (lanes 2, 4, 6, 9, 11, and 13) or 2,500 molar excess to probe (lanes 3, 5,
7, 10, 12, and 14) . (B) Competition analyses for protein binding to theDQ3.2(I) fragment, usingBSM nuclear extract and theDQ3 .2(I) probe. (Lane
1) No competitorDNA ; (lane 2) competition withDQ3.1(-279) ; (lane 3) competition with DQ3.1(-264); (lane 4) competition withDQ3.1(-232) .
Binding reaction contained 2,500 molar excess competitor DNA to probe.
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elements.
The 549-bp Hincll fragments from the DQ3.1 and DQ3.2
URR (positions -580 to -31) were inserted into the pTCAT
1W bp
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vector to generate the pQ3.10PICAT and pQ3.20P2CAT con-
structs, respectively. After transfection into BSM cells, the
DQ3.1 fragment gave CAT activity that was three- to four-
fold higher than the comparable DQ3.2 fragment (Fig. 6) .
Transfecting
DNA
Net CAT
￿
Net p-gal
Activity Activity Average Relative
(cpm)
￿
(OD
574)
￿
CAT/0-gal CAT Activity
Figure 6.
￿
Relative CAT activity among allelic DQ promoter fragments 48 h after transfection into BSM. Endonuclease sites are identified with
vertical bars. CCAAT, Y, X, W, and the adjacent dyad symmetry region indicated represent the locations of consensus sequences as described in the
text. Open bars indicate DQ3.1 sequences, crosshatching indicates DQ3.2 sequences, and solid bars indicate the pTCAT vector. NetCATActivity and
Net /3-gal Activity refer to total 14C cpm or to raw OD574 reading, respectively, minus the background values of transfected samples with no DNA
added. The average "No DNA" background in experiment A was 1,958 cpm for CAT activity and an OD574 reading of 0.049 for (3-galactosidase
activity, and in experiment B was 2,272 cpm . for CAT activity and 0.024 for /3-galactosidase activity. Measurements less than those for samples with
no DNA added are negative net values. Average CAT/0-galactosidase values were derived by dividing the mean net CAT activity by the mean net
/3-galactosidase activity, which was then normalized to give relative CAT activity by assigning the pQ3.1/3PICAT a value of 10.
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-'-w z Y our 8,182 0.551The pQ3.1,3P2CAT construct has the same DQ3.1 URR
fragment inserted in a reverse orientation, and serves as a nega-
tive control with CAT values equivalent to background CAT
activity, confirming the specificity of transcription initiation
by the inserted URR in "correct" orientation. Nucleotide
sequencing of all of the constructs studied confirmed the se-
quences displayed in Fig. 1 and also showed that the flanking
and joining regions in the vector were identical among the
fragments.
As indicated above, sequence and protein-binding studies
implicated polymorphic sites around the X box element and
upstream of the W box as potential sites of important URR
allelic variation. A plasmid was constructed where a portion
of the DQ3 .2 URR spanning the functionally important X
and W boxes was shuttled into the DQ3 .1 URR: restriction
endonuclease sites at positions -223 (AatII) and -158
(PpuMI) were used to cut out a 62-bp fragment in DQ3.1,
and the corresponding DQ3.2 fragment, which differs by five
nucleotides, was inserted in its place to form the hybrid con-
struct pQ3.10P3CAT. When compared in the transfection
assay to the unadulterated pQ3.10P1CAT and pQ3.20P2CAT
plasmids, its promoter "strength" was intermediate between
that of the 3.1 and the 3.2 URR alone, suggesting that this
region confers some, but not all, of the variation in tran-
scriptional activity between these allelic fragments.
To distinguish these sites offunctional promoter variation
from additional upstream contributions, two constructs were
generated by removing promoter sequences 5' of the AatII
site (-223) in the pQ3.10P1CAT and pQ3.20P2CAT con-
structs, generating pQ3.10P4CAT and pQ3.20P3CAT, respec-
tively. As shown in Fig. 6 B, allelic differences in these min-
imal promoters were still observed, but did not account for
all of the variation seen in transfections performed with longer
segments of the URR. Truncation of the DQ3 .2 URR to
remove upstream elements did not reduce promoter strength;
on the other hand, an identical deletion in the DQ3.1 URR
led to a 40% reduction in promoter strength. This indicates
that upstream elements in the DQ3.1 URR account for ap-
proximately half of the difference observed between the larger
allelic URR fragments.
Discussion
Polymorphism is the hallmark of the MHC. Nucleotide
variation in structural genes amongclosely related HLA class
II alleles is responsible for functionally significant amino acid
variation; these differences account for variation in peptide
binding properties (5, 6), allorecognition (4), and are likely
critical for susceptibility to HLA-associated diseases (2, 3).
This polymorphism is functionally amplified by variation in
combinatorial associations of various class 11 a and /3 poly-
peptides (39-41), so that allelic contributions to immune rec-
ognition are really quite complex. We now report an addi-
tional source ofvariation due to genetic polymorphism among
HLA class II genes, namely, allelic diversity in the promoter
and associated regulatory elements.
188
￿
HLA-DQB Regulatory Polymorphisms
The URR of the HLADQB1 locus includes both the min-
imal promoter elements necessary for transcription and ele-
ments important for tissue specificity and inducible regulation
(11-13, 42). We found up to 7% nucleotide polymorphism
within these upstream elements among seven DQB1 alleles.
URR sequences linked to specific structuralalleles were highly
conserved among different haplotypes; i.e., the DQ4 URR
were identical on DR8- and DR4-associated haplotypes, sug-
gesting that these polymorphisms are stable, and not recently
derived. Sequences derived from multiple cell lineswith the
same haplotypes were also identical for all URR analyzed.
Several of these polymorphisms occur at sites important
for transcriptional regulation. Analysis of nuclear proteins
that specifically bind to the URR ofthe DQB genesrevealed
at least two sites which differ markedly in affinity for DNA
binding proteins, because of the allelic nucleotide variation.
One of these sites is within a recognizedconsensus element,
the X box, which occurs in all murine and human class II
genes. DNA-binding proteins from cell line BSM bind avidly
to this region in the DQ3.2 URR, but much less so to the
same region in the DQ3.1 URR. The other variable site lies
upstream of the recognized consensus regions, and has the
opposite phenotype; that is, a DNA-binding protein was
identified which bindsto an upstream site within the DQ3.1
URR but does not bind under similar conditions to the cog-
nate site in the DQ3.2 URR.
Although these two polymorphic sites have different target
nucleotide sequences, it is possible that the proteins which
interact with these sites are related. Gel retardation studies
showed that the DNA-protein complex in the upstream
DQ3 .1 URR was competitively inhibited by X box oligo-
nucleotides, and vice versa. This relationship is also similar
to findings in the HLA-DRA promoter, in which upstream
("Z box") elements and X box elements are thought to bind
related regulatory proteins (42).
Promoter strength was evaluated for two of the allelic URR
that differ at these two polymorphic sites, using CAT as a
reporter gene for transient transfection assays in human B
cell lines. Consistent 3-5-fold differences in CAT activity were
found; URR constructions designed to separate the X box
from upstream elements demonstrated that both regions con-
tribute to these allelic differences. Patterns ofprotein binding
and hierarchy of CAT activity between the alleles were ob-
served to be similar with other B-LCLs.
These findings of allelic promoter variation can be related
to previous studies indicating interlocus variation among HLA
class 11 promoter elements. Regulatory regions of class II u
genes for the DR, DQ, and DP loci have been previously
compared for ability to bind selected nuclear proteins: The
X box binding protein, RF-X, does not recognize all X boxes
equally well and shows a gradient in X box binding affinity
with the profile DRA>DPA>DQA (18). A different pro-
tein, NF-S, binds downstreamof the X box motifand shows
binding characteristics that are the reverse: DQA>DPA>
DRA (19). Differences in promoter sequences with varying
affinities for X box binding proteins thus appear to account
for both inter- and intralocus variation. In our studies, com-petition and direct binding analyses indicate that one or both
of the nucleotides TG at positions -179 and -180 are re-
quired for the high affinity X box binding site in DQ3.2.
Two different X box binding proteins have previously been
described, termed NF-X and RF-X, which have been found
in a variety of cell types and both contact the center of the
X box motif and bases upstream (18, 43, 44). Whether these
proteins are related to the specific allelic interaction described
here is not yet known.
In studies of the DQ2 class II promoter, Sakurai and
Strominger (13) demonstrated that a 95-bp fragment from
-223 to -132 was sufficient to confer cell type--specific en-
hancer activity on a heterologous promoter. Our studyshows
that even small nucleotide variation between alleles in this
region significantly alters the activity of the URR. Shuttling
of a 62-bp promoter fragment from position -223 to -158
containing the conserved X and W box sequences from the
DQ3.2 URR into the DQ3.1 URR fragment gave inter-
mediate levels of transcriptional activity. However, since trun-
cation of the promoter sequences to -223 in the DQ3.1 con-
struct gave promoter activity that was 40% lower than the
construct containing 549 nucleotides of URR, it is clear that
additional upstream sequences contribute to transcriptional
regulation as well. These results correlate with the findings
that polymorphic sites differ in protein interactions not only
within the X box, but also at a more upstream polymorphic
site.
Transcriptional regulation of the DQB1 gene is undoubt-
edly a composite ofmultiple protein-DNA interactions, in-
volving both polymorphic and nonpolymorphic sites within
the URR. The principle nonpolymorphic sites include (a)
Potential binding sites for regulatory proteins AP4 and AP1,
from -40 to -27, which are nonpolymorphic between al-
leles; these are analogous to similar sites found in the SV40
late enhancer element, as well as in several cellular promoters,
where the juxtaposition of these elements contribute to in-
ducible transcriptional control (45, 46). (b) Two nonpoly-
morphic CCAATmotifs, one ofwhich is called the "Y box"
in class II promoters and contains the CCAAT motif in re-
verse orientation, and an additional polymorphic CCAAT
site which occurs only in the DQ3 .1 and DQU URR at
position -232. A large variety of CCAATbinding proteins
are recognized as ubiquitous transcriptional activatorsin many
systems (20, 47-49). (c) The nonpolymorphic potential regula-
tory site at -270 to -265, which has sequence homology
to the PU box, a purine-rich sequence recognized by a mac-
rophage and B cell-specific transcription factor PU.1 (38);
and (d) a nonpolymorphic ATF site at -227 to -222, which
may be important for regulation by cAMP (50-52) .
It is likely that these nonpolymorphic sites contribute to
regulatory properties common to all DQBI genes. In con-
trast, among the polymorphic sites, two were found to lead
to functional allele-specific consequences while the others,
as yet, have not. Siteswith both sequence polymorphism and
marked variation in DNA-protein interaction were identified
at -179 and at -279. The location of the -179 site in the
critical class II consensus X box region, and the large differ-
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ences seen in protein bindingbetween the DQ3.1 and DQ3.2
URR at this site suggest that this polymorphism may ac-
count for the transcriptional variation seen between the trun-
cated URR constructions shown in Fig. 6 B, and thus ac-
count for some of the overall differences between these two
alleles. In HLADQ, as in other class 11 genes, the X and
Y boxes are separated by a conserved number of nucleotides,
which however frequently varies in sequence (27, 53). Both
the X and Y box have been shown to be essential for tran-
scription and both have been implicated in IFN-y inducibility,
as has the W box area (11, 12, 54). A complex of regulatory
proteins appear to coordinately recognize the Xbox and nearby
sequences; the precise role ofeach element in this interaction
remains unknown.
The nature of the protein binding to the polymorphic site
at -279 is similarly unknown. A possibility is that the poly-
morphic site at -279 creates in the DQ3.1 URR an addi-
tional positive transcriptional recognition sequence. This is
a candidate site which may contribute to the increased tran-
scriptional activity of the DQ3.1 URR relative to DQ3.2,
specifically to the portion of the observed activity which is
due to elements upstream from the previously recognized con-
sensus regions.
Two additional polymorphic sites are of potential interest.
A polymorphic region of extensive dyad symmetry occurs
just upstream of the W box. With the A at position -214
forming the center, this symmetry stretches seven nucleo-
tides in each direction in the DQ3.1, DQ1, and DQ2 alleles.
However, a substituted G at position -211 disrupts the com-
plementarity in the DQ3.2, DQ3.3, and DQ4 alleles. A similar
dyad symmetry element has been described in the URR of
the HLA-DRA and IFN-0 genes (25, 55). In the IFN-a
URR, this site was implicated in negative regulation, whereas
disruption ofthe dyad symmetry element in the DRA URR
results in a decrease in promoter activity in B cells and an
increase in other cell types. In the DQBI URR, DNA-
protein interactions were found which corresponded to this
dyad symmetry element, but they were similar for the alleles
tested, in spite of the nucleotide polymorphism. Similarly,
the DQ3 .1, DQ2, DQ1.2, and DQ1.1 alleles, but not the
DQ3.2, DQ3.3, and DQ4 alleles, also have recognition se-
quences at the 3' end of the X box related to sites commonly
associated with a class of developmentally regulated DNA-
binding proteins (56).
MHC class II genes are primarily expressed on cells of the
lymphoid lineage; i.e., on mature B cells, activated T cells,
macrophages/monocytes, and other antigen-presenting cells
(57, 58). Additionally, cell surface expression ofclassII mol-
ecules can be induced in many cell types ofnonlymphoid origin
by exposure to cytokines such as IFN-y, leading to the ac-
quisition of antigen-presenting properties (59) . Other lym-
phokines and cellular factors have been shown to stimulate
(60--62) or repress class II gene expression (63, 64). Our data,
which indicate the presence of significant polymorphisms
within the transcriptional regulatory regions of different HLA
DQ alleles, point to the need to relate such allelic differences
to the control of DQ expression in B cells, other lymphoidcells, and tissues capable of expressing inducible HLA class
II molecules. In particular, since HLA class II expression in
specific organs is associated with triggering of autoimmu-
nity, transcriptional variation due to allele-specific promoter
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